Sotera Health Co (SHC) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs.
Total Cash From Operating Activities Chart for Sotera Health Co
Sotera Health Co (SHC) operating cash flow for FY2025 was USD 287.2M, a 28.1% change from FY2024. Sotera Health Co's operating cash flow grew from USD 13.3M in 1997 to USD 287.2M in 2025 (2058.5% over 28 years). Operating cash flow compound annual growth rate: 5-year CAGR of 19.0%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $5.21B
- Implied Share Price
- $18.25
- Enterprise Value
- $7.13B
- Revenue (TTM)
- $1.22B
- EBITDA
- $576.58M
- Profit Margin
- 13.44%
- Trailing P/E
- 32.02
- Forward P/E
- 17.76
- Price/Book (MRQ)
- 7.84
- Price/Sales (TTM)
- 4.28
- EV/EBITDA
- 13.38
- EV/Revenue
- 5.86
- Dividend Yield
- —
- Book Value
- $2.33
- Free Cash Flow (FY2025)
- $149.18M
- Free Cash Flow Yield
- 2.86%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.